Patents by Inventor Avtar K. SINGH

Avtar K. SINGH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220193181
    Abstract: The present disclosure provides methods for the treatment or prevention of SARS-Cov-2 infection or disease and IL-6 mediated immune/autoimmune and cancers by the administration of GSNO or GSNO reductase inhibitor.
    Type: Application
    Filed: December 21, 2021
    Publication date: June 23, 2022
    Applicant: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
    Inventors: Inderjit Singh, Avtar K. Singh
  • Patent number: 10925858
    Abstract: The present disclosure provides methods for the treatment of neurological deficits by the administration of GSNO or GSNO reductase inhibitor. Further provided herein are methods of treating autoimmune diseases by administering GSNO or GSNO reductase inhibitor.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: February 23, 2021
    Assignees: The US Government as Represented by the Department of Veterans Affairs, MUSC Foundation for Research Development
    Inventors: Inderjit Singh, Avtar K. Singh
  • Publication number: 20200054610
    Abstract: The present disclosure provides methods for the treatment of neurological deficits by the administration of GSNO or GSNO reductase inhibitor. Further provided herein are methods of treating autoimmune diseases by administering GSNO or GSNO reductase inhibitor.
    Type: Application
    Filed: May 8, 2018
    Publication date: February 20, 2020
    Applicants: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT, THE US GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
    Inventors: Inderjit SINGH, Avtar K. SINGH